Vitamin A induction of cleft palate

Area of Science:

• Teratology
• Developmental Biology
• Toxicology

Background:

• Hypervitaminosis A is a known teratogen.
• Understanding the differential teratogenicity of vitamin A forms is crucial for developmental toxicology.
• Previous models for cleft palate induction require refinement.

Purpose of the Study:

• To investigate the teratogenic potential of retinoic acid and retinyl acetate in inducing cleft palate in a rat model.
• To compare the potency of retinoic acid versus retinyl acetate as teratogens.
• To explore the mechanism of vitamin A-induced cleft palate by examining palatal shelf development.

Main Methods:

• Administration of high doses of retinoic acid and retinyl acetate to pregnant Charles River rats on days 13-15 of gestation.
• Attempted induction of cleft palate in rabbits using hypervitaminosis A (unsuccessful).
• Histological examination of fetal rat heads to assess palatal development.

Main Results:

• Both retinoic acid and retinyl acetate induced cleft palate in 90% of rat fetuses at high doses.
• Retinoic acid was a more potent teratogen than retinyl acetate, requiring a lower dose for cleft induction.
• Both vitamin A forms inhibited normal palatal shelf reorientation, with retinoic acid causing a longer delay (≥48 hours) compared to retinyl acetate (approx. 12 hours).

Conclusions:

• Retinoic acid is a significantly more potent teratogen than retinyl acetate in inducing cleft palate in rats.
• Vitamin A teratogenicity in palate development is linked to the disruption of normal palatal shelf reorientation timing.
• The rat model effectively demonstrates vitamin A-induced cleft palate, highlighting the differential effects of vitamin A forms.